Statens Serum Institut
Copenhagen S., Hovedstaden, Denmark
Purpose
to develop an economically donor-friendly IPV vaccine with a reduced IPV dose of at least 5 fold. This vaccine will despite the lower dose of IPV show an immunogenicity which equals or surpasses the current full dose IPV vaccine.
Division
Global Health
Date
November 2012
Region Served
EUROPE
Committed amount
$551,049
Grant topic
Discovery and Translational Sciences
Duration (months)
20
Grantee location
Copenhagen S., Hovedstaden, Denmark
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.